SAN DIEGO, April 24, 2012 /PRNewswire/ -- Cadence
Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company
focused on acquiring, in-licensing, developing and commercializing
proprietary product candidates principally for use in the hospital
setting, today announced that it will release its first quarter
ended March 31, 2012 financial
results on Thursday, May 3, 2012.
Cadence management will host a conference call and live webcast
to discuss the financial results on Thursday, May 3, 2012 at 1:30 pm Pacific Time (4:30
pm Eastern Time). Interested investors may participate in
the conference call by dialing (877) 303-9145 (domestic) or (760)
536-5203 (international). To access the webcast, please visit
the company's website at www.cadencepharm.com and go to the
Investor Relations page. A replay of the webcast will be
available approximately two hours after the call and remain
available on the company's website until the next quarterly
financial results call.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company
focused on acquiring, in-licensing, developing and commercializing
proprietary products principally for use in the hospital
setting. The current version of Cadence Pharmaceuticals'
corporate overview may be viewed on the "Investors" page of
www.cadencepharm.com, under "Events and Presentations."
Contacts:
|
William R.
LaRue
|
|
SVP &
Chief Financial
Officer
|
|
Cadence
Pharmaceuticals,
Inc.
|
|
858-436-1400
|
SOURCE Cadence Pharmaceuticals, Inc.